🇺🇸 FDA
Pipeline program

Placebo, Minirin, 4 mikrogramy/ml, roztwór do wstrzykiwań

2021/ABM/01/00010

Phase 3 small_molecule active

Quick answer

Placebo, Minirin, 4 mikrogramy/ml, roztwór do wstrzykiwań for Rare and ultra-rare glomerulonephritis is a Phase 3 program (small_molecule) at Bial Portela & Companhia S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Bial Portela & Companhia S.A.
Indication
Rare and ultra-rare glomerulonephritis
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials